Preventive PracticePrevmedNCT07829601
Prevention Habits of Medical Doctors
An observational study of Preventive Practice, run by University Hospital, Clermont-Ferrand at 1 site in France.
Trial summary
Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable. The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Preventive Practice
- What is being tested?
- PREVMED questionnaire
- How many people
- 500 participants
- Where
- 1 siteFrance
- Study dates
- 27 Jun 2025to Jun 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Physicians and medical residents volunteering to participate in the PREVMED study. Participants are recruited through an online REDCap® questionnaire distributed through various channels, including social networks, mailing lists, and flyers containing a link to the questionnaire.
Who may be able to join
- Physician or medical resident volunteering to participate in the study.
Who cannot join
- Person not willing to participate in the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Clermont-Ferrand University Hospital
Clermont-Ferrand, 63000
Frédéric Dutheil, PU-PH, +33473178260, fdutheil@chu-clermontferrand.fr
About this study
Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable.
The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these practices.
Read the detailed description
PREVMED is an observational cross-sectional questionnaire survey conducted among physicians and medical residents using an anonymous self-administered online questionnaire hosted on REDCap®.
The primary objective is to describe physicians' preventive practices. The secondary objective is to investigate the influence of sociodemographic, occupational, and lifestyle factors on these practices.
The questionnaire assesses preventive practices toward patients, including assessment, oral advice, written advice or treatment, and referral to dedicated consultations regarding physical activity, diet, tobacco, alcohol, cannabis, and sun exposure. It also investigates practices related to screening and prevention for several cancers, including lung, breast, cervical, prostate, and skin cancer.
Sociodemographic characteristics, lifestyle factors, and occupational characteristics of participating physicians are also collected.
The questionnaire is distributed to physicians and medical residents through an internet link using various channels, including social networks, mailing lists, and flyers. Data are collected anonymously.
- Conditions
- Preventive Practice
- Being tested
- PREVMED questionnaire
- Keywords
- Preventive practices, Physicians, Screening practices
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PREVMED questionnaireOther
Anonymous self-administered online questionnaire assessing physicians' preventive practices toward their patients, as well as sociodemographic, occupational, and lifestyle factors that may influence these practices.
| Study group | Role | What they receive |
|---|---|---|
| Physicians and medical residents | Not described Receives: Other: PREVMED questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assessment of patients' preventive health behaviors
Frequency of assessment of patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent assessment.
Measured: Baseline
Oral preventive advice provided to patients
Frequency of oral advice provided to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent provision of oral advice.
Measured: Baseline
Written preventive advice or treatment prescribed to patients
Frequency of written advice or treatment prescribed to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent prescription of written advice or treatment.
Measured: Baseline
Referral to dedicated preventive consultations
Frequency of referral of patients to dedicated consultations for physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent referral.
Measured: Baseline
Verification of recommended screening and medical examinations
Frequency with which physicians ensure that patients undergo mammography for organized breast cancer screening, cervical screening, fecal occult blood testing for organized colorectal cancer screening, and regular blood tests. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent verification.
Measured: Baseline
Lung cancer screening practice
Frequency of proposing lung cancer screening to asymptomatic patients at risk, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of lung cancer screening.
Measured: Baseline
Breast palpation practice
Frequency of proposing breast palpation to patients, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of breast palpation.
Measured: Baseline
Cervical screening practice
Frequency of proposing cervical screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of cervical screening.
Measured: Baseline
Prostate cancer screening practice
Frequency of proposing prostate cancer screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of prostate cancer screening.
Measured: Baseline
Recommendation of skin self-examination
Frequency of advising patients to perform skin self-examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent recommendation of skin self-examination.
Measured: Baseline
Visual skin examination
Frequency of performing visual skin examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent visual skin examination.
Measured: Baseline
Frequency of screening blood tests
Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.
Measured: Baseline
Secondary outcomes (34)
Tobacco cessation treatments prescribed
Types of treatment prescribed for smoking cessation, including varenicline, nicotine patches, nicotine gum, bupropion, cytisine, and electronic cigarettes. Multiple responses are permitted.
Measured: Baseline
Screening blood tests prescribed
Types of screening blood tests prescribed, including complete blood count, lipid profile, blood glucose, renal function, viral serology, inflammatory markers, and other tests. Multiple responses are permitted.
Measured: Baseline
Frequency of screening blood tests
Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.
Measured: Baseline
Criteria used for lung cancer screening
Criteria used to propose lung cancer screening, including smoking, occupational exposure, non-occupational exposure, family history of lung cancer, and other criteria. Multiple responses are permitted.
Measured: Baseline
Lung cancer screening method
Methods used for lung cancer screening, including chest radiography, chest computed tomography, pulmonary function testing, and other methods. Multiple responses are permitted.
Measured: Baseline
Frequency of lung cancer screening
Reported frequency of lung cancer screening according to the predefined categories of the questionnaire.
Measured: Baseline
Factors limiting lung cancer screening
Factors limiting prescription of lung cancer screening, including lack of recommendations, insufficient scientific evidence, insufficient knowledge of the topic, limited access to imaging, lack of patient adherence, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.
Measured: Baseline
Criteria used for breast palpation
Criteria used to propose breast palpation, including systematic examination, age, clinical symptoms, family history of breast cancer, prolonged hormonal exposure, and other risk factors. Multiple responses are permitted.
Measured: Baseline
Factors limiting breast palpation
Factors limiting breast palpation, including lack of time, lack of training, fear of being accused of inappropriate touching, lack of recommendations, insufficient scientific evidence, lack of patient adherence, follow-up already provided by another physician, and teaching patients breast self-examination. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.
Measured: Baseline
Factors limiting cervical screening
Factors limiting cervical screening, including lack of time, lack of training, fear of being accused of inappropriate touching, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.
Measured: Baseline
Criteria used for prostate cancer screening
Criteria used to propose prostate cancer screening, including systematic screening, age, clinical symptoms, family history of prostate cancer, ethnicity, and other risk factors. Multiple responses are permitted.
Measured: Baseline
Prostate cancer screening method
Method used for prostate cancer screening, categorized as digital rectal examination alone, prostate-specific antigen (PSA) testing alone, or digital rectal examination combined with PSA testing.
Measured: Baseline
Factors limiting prostate cancer screening
Factors limiting prostate cancer screening, including lack of time, lack of training, fear of being accused of inappropriate touching, lack of recommendations, insufficient scientific evidence, lack of patient adherence, and follow-up already provided by another physician. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.
Measured: Baseline
Criteria used for visual skin examination
Criteria used to perform visual skin examination, including systematic examination, light skin phototype, age, clinical symptoms, family history of skin cancer, frequent or excessive sun exposure, numerous nevi, and other risk factors. Multiple responses are permitted.
Measured: Baseline
Factors limiting skin cancer screening
Factors limiting skin cancer screening, including lack of time, lack of training, absence of a dermatoscope, fear of being accused of inappropriate examination, lack of recommendations, insufficient scientific evidence, lack of patient adherence, follow-up already provided by another physician, and teaching patients skin self-examination. Each factor is assessed using a visual analog scale ranging from 0 (minimum) to 100 (maximum), with higher scores indicating a greater perceived limitation.
Measured: Baseline
Professional status
Professional status of the participant, categorized as physician or medical resident.
Measured: Baseline
Medical specialty
Medical specialty of the participant, categorized as general practice, medical specialty, surgery, or psychiatry. Medical and surgical specialties are further specified according to the predefined categories of the questionnaire.
Measured: Baseline
Practice area
Geographical practice area, categorized as rural, urban, or semi-urban.
Measured: Baseline
Practice setting
Practice setting of the participant, including private practice, hospital practice, salaried practice, no current practice, retired, or other. Multiple responses are permitted.
Measured: baseline
Working environment
Working environment, including working alone, group practice, multidisciplinary health center, Maison Sport Santé, with secretarial support, or without secretarial support. Multiple responses are permitted.
Measured: Baseline
Supervision of students
Supervision of students, categorized as yes or no.
Measured: Baseline
Number of patients per week
Total number of patients seen per week, categorized as 0, 1-20, 20-50, 50-100, 100-150, or more than 150 patients per week.
Measured: Baseline
Weekly working time
Total working time per week, categorized as 0, 1-10, 10-20, 20-30, 30-40, 40-50, or more than 50 hours per week.
Measured: Baseline
On-call duties
On-call duties assessed separately for private practice and hospital practice, with each categorized as yes or no.
Measured: Baseline
Tobacco consumption
Daily tobacco consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 cigarettes per day.
Measured: Baseline
Alcohol consumption
Weekly alcohol consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 alcoholic drinks per week.
Measured: Baseline
Cannabis consumption
Weekly cannabis consumption, categorized as 0, 1-4, 5-9, 10-14, 15-19, or more than 20 joints per week.
Measured: Baseline
Daily sitting time
Total time spent sitting per day, expressed in hours per day and recorded from 0 to 24 hours in 30-minute increments.
Measured: Baseline
Leisure-time physical activity
Time spent in leisure-time physical activity, expressed in hours per week and recorded from 0 to 24 hours in 30-minute increments.
Measured: Baseline
Body mass index
Body mass index calculated automatically from self-reported height in centimeters and weight in kilograms, expressed in kg/m².
Measured: Baseline
Age
Age of the participant, expressed in years.
Measured: Baseline
Gender
Gender of the participant, categorized as male or female.
Measured: Baseline
Family status
Family status of the participant, categorized as single or in a couple.
Measured: Baseline
Number of children
Total number of children reported by the participant.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2026
- Study start27 Jun 2025
- Primary completionJun 2028 (estimated)
- Study completionJun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Preventive PracticeStudies of the same condition, open and under way.
- More trials run by University Hospital, Clermont-FerrandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07829601
- Sponsor's protocol ID
- 2026_DUTHEIL_Prevmed
- Acronym
- Prevmed
- Status last verified
- Sep 2026
- First submitted
- 14 Sep 2026
- Last updated
- 24 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevention Habits of Medical Doctors
- ClinicalTrials.gov ID
- NCT07829601
- Acronym / sponsor ID
- Prevmed / 2026_DUTHEIL_Prevmed
- Conditions
- Preventive Practice
- Keywords
- Preventive practices, Physicians, Screening practices
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- University Hospital, Clermont-FerrandUniversity, hospital or other
- Study start
- 27 Jun 2025 (actual)
- Primary completion
- Jun 2028 (estimated)
- Study completion
- Jun 2028 (estimated)
- First posted
- 21 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Preventive practices among physicians remain insufficiently studied, particularly in situations for which recommendations are limited or unavailable.
The PREVMED study aims to describe physicians' preventive practices and to investigate the sociodemographic, occupational, and lifestyle factors that may influence these practices.
Detailed description
PREVMED is an observational cross-sectional questionnaire survey conducted among physicians and medical residents using an anonymous self-administered online questionnaire hosted on REDCap®.
The primary objective is to describe physicians' preventive practices. The secondary objective is to investigate the influence of sociodemographic, occupational, and lifestyle factors on these practices.
The questionnaire assesses preventive practices toward patients, including assessment, oral advice, written advice or treatment, and referral to dedicated consultations regarding physical activity, diet, tobacco, alcohol, cannabis, and sun exposure. It also investigates practices related to screening and prevention for several cancers, including lung, breast, cervical, prostate, and skin cancer.
Sociodemographic characteristics, lifestyle factors, and occupational characteristics of participating physicians are also collected.
The questionnaire is distributed to physicians and medical residents through an internet link using various channels, including social networks, mailing lists, and flyers. Data are collected anonymously.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Physicians and medical residents | – | Other: PREVMED questionnaire |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Physicians and medical residents volunteering to participate in the PREVMED study. Participants are recruited through an online REDCap® questionnaire distributed through various channels, including social networks, mailing lists, and flyers containing a link to the questionnaire.
Key inclusion criteria (1 listed)
- Physician or medical resident volunteering to participate in the study.
Key exclusion criteria (1 listed)
- Person not willing to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PREVMED questionnaireAnonymous self-administered online questionnaire assessing physicians' preventive practices toward their patients, as well as sociodemographic, occupational, and lifestyle factors that may influence these practices. | Other | Physicians and medical residents |
Primary outcome
Assessment of patients' preventive health behaviors
Time frame: Baseline
Frequency of assessment of patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent assessment.
Oral preventive advice provided to patients
Time frame: Baseline
Frequency of oral advice provided to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent provision of oral advice.
Written preventive advice or treatment prescribed to patients
Time frame: Baseline
Frequency of written advice or treatment prescribed to patients regarding physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent prescription of written advice or treatment.
Referral to dedicated preventive consultations
Time frame: Baseline
Frequency of referral of patients to dedicated consultations for physical activity, diet, tobacco consumption, alcohol consumption, cannabis consumption, and sun exposure. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent referral.
Verification of recommended screening and medical examinations
Time frame: Baseline
Frequency with which physicians ensure that patients undergo mammography for organized breast cancer screening, cervical screening, fecal occult blood testing for organized colorectal cancer screening, and regular blood tests. Each item is assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent verification.
Lung cancer screening practice
Time frame: Baseline
Frequency of proposing lung cancer screening to asymptomatic patients at risk, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of lung cancer screening.
Breast palpation practice
Time frame: Baseline
Frequency of proposing breast palpation to patients, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of breast palpation.
Cervical screening practice
Time frame: Baseline
Frequency of proposing cervical screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of cervical screening.
Prostate cancer screening practice
Time frame: Baseline
Frequency of proposing prostate cancer screening, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent proposal of prostate cancer screening.
Recommendation of skin self-examination
Time frame: Baseline
Frequency of advising patients to perform skin self-examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent recommendation of skin self-examination.
Visual skin examination
Time frame: Baseline
Frequency of performing visual skin examination, assessed using a visual analog scale ranging from 0 (never) to 100 (always), with higher scores indicating more frequent visual skin examination.
Frequency of screening blood tests
Time frame: Baseline
Frequency of prescription of screening blood tests, categorized as occasionally without a defined frequency, once a year, once every 2 years, every 3 to 5 years, more than 5 years apart, or more than 10 years apart.
34 secondary outcomes
Tobacco cessation treatments prescribed
Time frame: Baseline
Screening blood tests prescribed
Time frame: Baseline
Frequency of screening blood tests
Time frame: Baseline
Criteria used for lung cancer screening
Time frame: Baseline
Lung cancer screening method
Time frame: Baseline
Frequency of lung cancer screening
Time frame: Baseline
Factors limiting lung cancer screening
Time frame: Baseline
Criteria used for breast palpation
Time frame: Baseline
Factors limiting breast palpation
Time frame: Baseline
Factors limiting cervical screening
Time frame: Baseline
Criteria used for prostate cancer screening
Time frame: Baseline
Prostate cancer screening method
Time frame: Baseline
Factors limiting prostate cancer screening
Time frame: Baseline
Criteria used for visual skin examination
Time frame: Baseline
Factors limiting skin cancer screening
Time frame: Baseline
Professional status
Time frame: Baseline
Medical specialty
Time frame: Baseline
Practice area
Time frame: Baseline
Practice setting
Time frame: baseline
Working environment
Time frame: Baseline
Supervision of students
Time frame: Baseline
Number of patients per week
Time frame: Baseline
Weekly working time
Time frame: Baseline
On-call duties
Time frame: Baseline
Tobacco consumption
Time frame: Baseline
Alcohol consumption
Time frame: Baseline
Cannabis consumption
Time frame: Baseline
Daily sitting time
Time frame: Baseline
Leisure-time physical activity
Time frame: Baseline
Body mass index
Time frame: Baseline
Age
Time frame: Baseline
Gender
Time frame: Baseline
Family status
Time frame: Baseline
Number of children
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2026.
Related trials for Preventive Practice
Not yet recruiting
Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits
Short Message Service (SMS), Incentives
Not yet recruiting
Assessing the Impact of a Social Media-Based Educational Intervention Using WhatsApp Video Messages on Dental Caries Prevention Knowledge, Oral Hygiene Practices, and Attitudes Toward Dental Health Among Primary School Children Aged 10-12 Years in Public Schools in Cairo Governorate, Egypt: A Quasi-
Dental Caries, Oral Health Behavior Change
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Preventive Practice, run by University Hospital, Clermont-Ferrand at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Frédéric Dutheil, PU-PH (+33473178260, fdutheil@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assessment of patients' preventive health behaviors (time frame: Baseline). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026; AzTrials last refreshed its copy on 7 Nov 2026.